Valuation: Takeda Pharmaceutical Company Limited

Market Cap 9,494B 60.94B 53.07B 50.23B 45.64B 85.26B 5,836B 85.68B 598B 231B 2,966B 229B 224B P/E 2027 *
47.1x
P/E 2028 * 29.9x
Enterprise Value 13,401B 86.01B 74.91B 70.9B 64.42B 120B 8,237B 121B 844B 327B 4,186B 323B 316B EV / Sales 2027 *
2.85x
EV / Sales 2028 * 2.76x
Free-Float
99.26%
Yield 2027 *
3.44%
Yield 2028 * 3.5%
1 day+4.14%
1 week+6.63%
Current month+7.40%
1 month+9.32%
3 months+23.54%
6 months+5.44%
Current year+27.06%
1 week 31.28
Extreme 31.28
33.53
1 month 29.97
Extreme 29.97
33.53
Current year 25.46
Extreme 25.46
33.53
1 year 22.45
Extreme 22.45
33.53
3 years 22.45
Extreme 22.45
33.53
5 years 22.45
Extreme 22.45
33.53
10 years 22.45
Extreme 22.45
50
Manager TitleAgeSince
Chief Executive Officer 56 01/01/2025
Director of Finance/CFO 48 01/04/2024
Chief Tech/Sci/R&D Officer 47 01/02/2022
Director TitleAgeSince
Director/Board Member 60 01/06/2015
Director/Board Member 73 01/01/2019
Director/Board Member 48 01/06/2024
Change 5-day change 1-year change 3-year change Capi.($)
+3.29%+6.63% - - 60.2B
+1.28%+2.62%+51.61%+101.73% 1,014B
+1.10%+1.45%+52.49%+66.32% 644B
+0.58%+3.54%+19.57%+71.51% 464B
-0.36%+3.88%+39.78%+38.21% 354B
+1.52%+3.90%+19.76%+25.75% 265B
+2.41%+6.68%+9.54%+13.60% 253B
+0.91%-0.70%+38.25%+44.32% 203B
+2.48%-3.31%-22.21%-58.09% 186B
+2.17%+4.20%+34.41%+99.54% 183B
Average +1.61%+0.96%+27.02%+44.77% 396.31B
Weighted average by Cap. +1.21%+1.41%+35.58%+61.48%

Financials

2027 *2028 *
Net sales 4,701B 30.17B 26.28B 24.87B 22.6B 42.21B 2,889B 42.42B 296B 115B 1,468B 113B 111B 4,782B 30.69B 26.73B 25.3B 22.99B 42.94B 2,939B 43.16B 301B 117B 1,494B 115B 113B
Net income 196B 1.26B 1.1B 1.04B 945M 1.76B 121B 1.77B 12.38B 4.79B 61.38B 4.74B 4.63B 323B 2.07B 1.8B 1.71B 1.55B 2.9B 198B 2.91B 20.34B 7.86B 101B 7.78B 7.61B
Net Debt 3,907B 25.07B 21.84B 20.67B 18.78B 35.08B 2,401B 35.25B 246B 95.19B 1,220B 94.19B 92.09B 3,702B 23.76B 20.7B 19.59B 17.8B 33.25B 2,276B 33.41B 233B 90.21B 1,156B 89.26B 87.27B
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,029
Date Price Change Volume
17/09/26 32.96 +3.29% 150
16/09/26 €31.91 -1.21% 0
15/09/26 €32.30 +0.06% 200
14/09/26 €32.28 +3.20% 225
11/09/26 €31.28 -0.22% 100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
5,946.00JPY
Average target price
6,622.06JPY
Spread / Average Target
+11.37%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!